Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) Receivables - Other (2017 - 2024)

Pediatrix Medical (MD) has disclosed Receivables - Other for 8 consecutive years, with $28.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Receivables - Other fell 14.16% to $28.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $28.5 million, a 14.16% decrease, with the full-year FY2024 number at $28.5 million, down 14.16% from a year prior.
  • Receivables - Other was $28.5 million for Q4 2024 at Pediatrix Medical, down from $33.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $61.4 million in Q4 2020 to a low of $28.5 million in Q4 2024.
  • A 5-year average of $47.2 million and a median of $54.7 million in 2022 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: surged 106.04% in 2020, then tumbled 39.31% in 2023.
  • Pediatrix Medical's Receivables - Other stood at $61.4 million in 2020, then dropped by 5.37% to $58.1 million in 2021, then dropped by 5.85% to $54.7 million in 2022, then crashed by 39.31% to $33.2 million in 2023, then decreased by 14.16% to $28.5 million in 2024.
  • Per Business Quant, the three most recent readings for MD's Receivables - Other are $28.5 million (Q4 2024), $33.2 million (Q4 2023), and $54.7 million (Q4 2022).